Brief report
Autism spectrum disorders (ASD) are highly inherited developmental syndromes, resulting from a complex interaction between environmental and genetic factors. To date, only a limited number of genetic variants have been discovered with respect to autism. Mutations of the fragile X mental retardation protein (FXMRP) account for 5% of ASD cases. Genes such as Neuroligin X, SHANK2, SHANK3, CNTNAP2, EN2 and MET among others have also been reported in association with ASD (State, 2010) , although their contribution to the development of the disorder has not been clearly determined. Investigation of specific autistic symptomatology may improve the chances of identifying related genes and may help to better understand these disorders.
The disruption of the serotonin (5-HT) system is one of the most consistent and well-replicated findings in ASD (Zafeiriou et al., 2009) . Increase in platelet serotonin levels was the first finding to relate 5-HT to ASD (Zafeiriou et al., 2009; Hammock et al., 2012) , with hyperserotonemia observed in 25-50% of patients with ASD (Zafeiriou et al., 2009) . Sequence variants in the serotonin genes may contribute to this disruption, and several studies have investigated their involvement in the development of ASD. The serotonin transporter (5-HTT) gene is a strong autism candidate because of its association with anxiety, aggression, attention and the effectiveness of selective serotonin reuptake inhibitors in treating certain behavioural symptoms (Brune et al., 2006) , and it is located in an area linked to autism, 17q11. A polymorphism in the promoter region of this gene (SLC6A4 LPR) was found associated with the disorder (Brune et al., 2006; Calahorro et al., 2009) , level of language impairment (Kistner-Griffin et al., 2011) and childhood aggression (Beitchman et al., 2006) . Genetic variants in 5-HT1B, 5-HT2A, 5-HT3A, 5-HT3C and 5-HT4A receptor genes have also been linked to the predisposition to ASD (Coutinho et al., 2004; Anderson et al., 2009; Orabona et al., 2009; Hranilovic et al., 2010) . However, most of these findings have not been replicated in independent studies, and the reported genetic effects are relatively small. We propose to investigate the genetic contribution to specific phenotypes within ASD, such as intelligence quotation (IQ) and its components, intellectual disability (ID) and language onset delay (LD). This may facilitate the identification of related genes and help to better understand the pathophysiology of the disease.
A total of 141 children and young adults (121 male patients and 20 female patients, average age 14.5 5.1 years) were recruited at the Child Psychiatric Unit of the Hospital Universitari Mútua Terrassa (HUMT, Barcelona, Spain). All patients were unrelated and fulfilled diagnosis of autistic spectrum disorders (ASD) according to DSM-IV-TR, Autism-Diagnostic Interview-Revised and Autism Diagnostic Observation Schedule (Lord et al., 2000a (Lord et al., , 2000b . Intellectual capacity was measured by the Wechsler intelligence scale for children [Wechsler Adult Intelligence Scale Revised. (WAIS-IV)] or by the Wechsler adult intelligence scaleRevised. Full scale IQ was the principal IQ measure. If differences among Wechsler subscales were 23 points or more, the General Ability Index was calculated and taken as principal IQ measure. Participants had an average IQ of 88.41 (SD = 20.28). ID was defined by a full scale IQ of 70 or less. Language delay was defined as onset of first meaning words later than 24 months or onset of two word phrases later than 33 months. ID and LD were observed in 37 and 36% of the participants, respectively. Karyotype analyses and Fragile X testing was conducted in all patients. All study participants and their tutors gave written consent to participate in this study, which has been approved by the HUMT Ethics Committee. This sample size has a statistical power of 80-85% to detect genetic effects, with an odds ratio of 2.5 for polymorphisms with a minimum allele frequency of 0.15 or higher (considering 240 chromosomes, calculated with EpiInfo v7.0.8.3; Centers for Disease Control and Prevention, Atlanta, Georgia, USA).
Eighty tagged single nucleotide polymorphisms (SNPs) in 15 serotonin genes were chosen using the HapMap programme (http://www.hapmap.org) and the parameters r2 less than 0.85 and minimum allele frequency greater than 0.15 (see Table 1 for list of polymorphisms and Table 2 for linkage disequilibrium figures in our sample). DNA was extracted from whole blood samples using the standard methods. Genotyping was performed using SNPlex technology (Applied Biosystems, Foster City, California, USA). Linear regression analyses, including age and sex as covariates, and χ 2 analyses were calculated to investigate the associations with linear (IQ) and bimo dal variables (ID and LD). Phased (using the E-M algo rithm) haplotype analyses including all SNPs within a gene were performed (data available on request). The statistical packages SPSS (v2.0; IBM, Armonk, New York, USA), PLINK (v1.07) (Purcell et al., 2007) and EpiInfo (v7.0.8.3 ; IBM) were used. Table 3 summarizes the results of the analyses. In general, the allelic frequencies agree with those observed in previous studies on unaffected Spanish controls, although there are no data for some of the polymorphisms investigated in our study. Several serotonin polymorphisms were associated with the level of IQ in our cohort. The most significant finding was the association with the 5-HT2B receptor gene (HTR2B) rs10194776 polymorphism (P = 0.0004), a finding still significant after corrections for multiple analyses (correction factor: 15 genes × 3 = 45). This same polymorphism was also found associated with ID (P = 0.02) and LD (P = 0.04), although these marginal associations did not survive multiple analyses corrections. A second HTR2B polymorphism, rs16827801, was also significantly associated with IQ, ID and LD, respectively, confirming the relevance of this gene. Haplotype analyses revealed association between allelic combinations of HTR2B SNPs and IQ, ID and LD. No information on the functional effect of these polymorphisms exists, and no significant influence on HTR2A rs2070040, rs9534511, rs2296973, rs2770304, rs1410657, rs2770296, rs4941570, rs2770293, rs6561335, rs2224721, rs7984966, rs9534495, rs2770300, rs1923887, rs6561333, rs6561332, rs7997012, rs7322347 5-HT2B HTR2B rs10194776, rs16827801, rs4973377 5-HT3A
HTR3A rs1150222, rs1176717, rs10160548 5-HT3B HTR3B rs1985242, rs11214763, rs12270070, rs1176744, rs11214775, rs1672717, rs7129190 5-HT4 HTR4 rs6865654, rs9686886, rs7721747, rs10223307, rs7711800, rs2910098, rs6873382, rs13166761, rs1368384, rs2005953, rs4597955, rs3995090, rs13156542, rs4274967 5-HT5A
HTR5A rs6320, rs2241859, rs2581841, rs6597455, rs1657268 5-H-T6 HTR6 rs4912138, rs9659997 5-HT7 HTR7 rs1298056, rs11817364, rs1274446, rs7904560, rs7916403, rs11186320, rs12261011, rs10785973, rs2226116, rs7084468, rs12259062 5-HTT SLC6A4 rs2020942, rs140701 TPH TPH1 rs10488683, rs172423, rs1800532, rs211102
regulatory factors was predicted using the FuncPred programme (http://snpinfo.niehs.nih.gov/snpinfo/snpfunc. htm). However, a nearby stop codon polymorphism, Q20*, had previously been related to antisocial personality and impulsivity, and studies in knockout mice related this polymorphism to impulsivity (Bevilacqua et al., 2010) . Our findings suggest that HTR2B polymorphisms may contribute to specific phenotypes within ASD, and the relationship of these polymorphisms with impulsivity should be investigated.
ID was significantly associated with several 5-HT2A receptor gene (HTR2A) polymorphisms and haplotypes (P = 0.03). Interestingly, this significant effect was not observed when analysing LD and IQ, suggesting that HTR2A variant affects specifically ID. Several lines of evidence suggest that 5-HT2A may play a role in ASD. Higher level of 5-HT2A receptor expression has been observed in ASD patients (Kazek et al., 2010) . Significant reduction in cortical 5-HT2A receptor binding has been observed in patients with Asperger's syndrome and has been related to abnormal social communication (Murphy et al., 2006) . In addition, numerous studies have reported associations between HTR2A polymorphisms and cognitive impairment and memory (Uçok et al., 2007; Hasselbalch et al., 2008; Sigmund et al., 2008; Wagner et al., 2008; Alfimova et al., 2010) . Our results contribute evidence supporting the involvement of 5-HT2A receptor alterations on cognitive impairment in ASD patients.
Two 5-HT6 receptor gene (HTR6) SNPs and a haplotype were significantly associated with IQ. Although no report has directly associated 5-HT6 receptors with ASD, these receptors are involved in learning, memory processes and cognitive impairment (Da Silva Costa-Aze et al., 2012) . Our data would suggest that HTR6 genetic variants contribute to cognitive impairment in ASD patients.
In addition to HTR2B variants, LD was significantly associated to 5-HT4 receptor gene (HTR4) polymorphisms and haplotypes. Previous studies have implicated 5-HT4 receptors with learning processes (King et al., 2008; Marchetti et al., 2008 , Levallet et al., 2009 . However, this is the first report associating HTR4 variants with LD or with ASD. Other interesting associations were detected between HTR1F, HTR2A and HTR7 genetic variants and IQ, ID and/or LD. However, these findings were marginal and require confirmation. We did not find clear correlations between the phenotypes investigated and SLC6A4 polymorphisms, and we cannot confirm their involvement in the development of IQ, ID and LD phenotypes. In general, factors such as age or sex did not affect the significance of our results. However, the findings of association of this study would not survive conservative corrections for multiple analyses, with the exception of the HTR2B findings. Nevertheless, the replication of the association in several SNPs and haplotypes of the same genes and the existing evidence of serotonergic dysfunction in ASD patients suggest that these results may be true findings.
One of the limitations of our study is the relatively modest sample size, which is underpowered to detect small genetic effects (odds ratios <2.5). In addition, the limited number of female patients included in our cohort did not allow for separate male-female comparisons. However, reanalyses of the 121 male participants produced similar results (data not shown). Finally, the functional effect of the SNPs found in association with ASD phenotypes is so far unknown, hindering the biological plausibility of the findings.
In summary, we have identified novel associations between genetic variants in 5-HT2B, 5-HT6 and 5-HT4 receptor genes and IQ, ID and LD and have provided further evidence of the relevance of other serotonin genes in cognitive impairment in ASD patients. Bold indicates significant P values (P < 0.05). ID, intellectual disability; IQ, intelligence quotation; LD, language onset delay; OR, odds ratio; SNP, single nucleotide polymorphism.
